Zelboraf Approved for Late-Stage Melanoma

The FDA today approved Zelboraf (vemurafenib) for the treatment of advanced or metastatic melanoma. The drug extends survival for the 50% of melanoma patients whose tumors carry the BRAF mutation.

Click here to read the full story.

Post a Comment

No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.